Soluble guanylate cyclase stimulator attenuates acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs

Oleg V. Evgenov(Bayer (Germany)), Warren M. Zapol(Harvard University), Natalia V. Evgenov(Bayer (Germany)), Mark Jean Gnoth(Bayer (Germany)), Fumito Ichinose(Harvard University), Kenneth D. Bloch(Harvard University)
BMC Pharmacology
June 1, 2005
10.1186/1471-2210-5-s1-s28
Cited by 1

Related Papers

Inhaled Nitric Oxide
|Circulation|2004|533
Mitochondrial dysfunction remodels one-carbon metabolism in human cells
|eLife|2016|455
The pulmonary vascular lesions of the adult respiratory distress syndrome.
|PubMed|1983|432
Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways
|Cell|1986|275
Pulmonary Vasoconstriction and Hypertension in Mice With Targeted Disruption of the Endothelial Nitric Oxide Synthase (NOS 3) Gene
|Circulation Research|1997|251